Bethesda, MD, United States of America

Hilton B Levy

This inventor holds 5 USPTO granted patents. Top assignees: The United States of America as Represented by the Department of Health, The United States of America as Represented by the Secretary of, The United States of America as Represented by the Secretary of Health. Active years: 1976-1983.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hilton B Levy. Retrieved from https://idiyas.com/inventor/hilton-b-levy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.4

ph-index = 5

Forward Citations = 76(Granted Patents)


Company Filing History:


Years Active: 1976-1983

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Hilton B Levy

Introduction

Hilton B Levy is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of biochemistry, particularly in the development of innovative complexes that enhance antiviral responses in hosts. With a total of 5 patents, his work has had a profound impact on medical research and treatment methodologies.

Latest Patents

Levy's latest patents include a low molecular weight complex of polyriboinosinic-polyribocytidylic acid. This nuclease-resistant hydrophilic complex combines polyriboinosinic-polyribocytidylic acid, poly-l-lysine, and carboxymethylcellulose. The complex is designed to induce the synthesis of antiviral levels of interferon in hosts while minimizing toxicity reactions typically associated with larger molecular weight complexes. Another significant patent involves a similar nuclease-resistant hydrophilic complex, which is effective when administered in a pharmacologically acceptable aqueous carrier, such as saline solution, to induce antiviral responses in both human and non-human primate hosts.

Career Highlights

Throughout his career, Levy has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the Secretary of Health. His research has been pivotal in advancing our understanding of antiviral therapies and their applications.

Collaborations

Levy has collaborated with notable colleagues such as John L Gerin and Thomas C Merigan. These partnerships have contributed to the success and impact of his research in the field.

Conclusion

Hilton B Levy's innovative work in developing antiviral complexes showcases his dedication to advancing medical science. His contributions continue to influence the field and provide new avenues for research and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…